Dual Activity Lysophosphatidic Acid Receptor Pan-Antagonist/Autotaxin Inhibitor Reduces Breast Cancer Cell Migration In vitro and Causes Tumor Regression In vivo

Signal transduction modifiers that modulate the lysophosphatidic acid (LPA) pathway have potential as anticancer agents. Herein, we describe metabolically stabilized LPA analogues that reduce cell migration and invasion and cause regression of orthotopic breast tumors in vivo. Two diastereoisomeric...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Zhang, Honglu, Xu, Xiaoyu, Gajewiak, Joanna, Tsukahara, Ryoko, Fujiwara, Yuko, Liu, Jianxiong, Fells, James I., Perygin, Donna, Parrill, Abby L., Tigyi, Gabor, Prestwich, Glenn D.
Formato: Artigo
Idioma:Inglês
Publicado: 2009
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3446773/
https://ncbi.nlm.nih.gov/pubmed/19509223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-09-0302
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares